RIGL Q1 2018 Earnings — Rigel Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RIGLRigel Pharmaceuticals, Inc.

$517M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$11M

Operating Income

-$25M

Net Income

-$24M

EPS (Diluted)

$-1.66

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$24M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$99M

Total Liabilities

$19M

Stockholders' Equity

$80M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$4M	-100.0%
Gross Profit	-$11M	-$9M	-27.9%
Operating Income	-$25M	-$16M	-52.7%
Net Income	-$24M	-$15M	-59.2%